Indradeep Bhattacharya

Indra Bhattacharya has more than eight years of experience in high-value IP disputes across a range of industry sectors, including pharmaceuticals, biotechnology, and medical devices. He also is experienced in commercial IP matters and in technology-rich corporate transactions. Indra is technically qualified with a degree in genetics and biochemistry.

Indra has acted for some of world's leading pharmaceutical and medical device companies, including Abbott, Celgene, Actavis, Convatec, Hospira, and Merck in various high-profile patent disputes. A number of these have been multijurisdictional in nature. He also has acted on trademark, design rights, and breach of confidence cases in the technology and retail sectors. He is experienced litigating before English and Australian courts.

Indra has significant IP commercial and regulatory experience as well, having spent time in-house at Hospira and at CSIRO, Australia's largest research organization. One of his key areas of focus is in digital health where he has advised Fujitsu, Samsung, and other technology companies on the legal and regulatory challenges facing the sector. Indra also has particular experience advising clients on IP protection of software and software licensing.

In addition, Indra has lectured on intellectual property law.